Latest filing published 12 May 2017 for Merrimack Pharmaceuticals INC, €14k.
Filing timeline
BuySaleInsider track record
Daryl C. Drummond: trading record in brief
Daryl C. Drummond is a declared insider of Merrimack Pharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 2 filings, every one of them for a trade on 12 May 2017.
No open-market purchase appears, only 1 sale worth €14k. Outside the open market, there are 1 option exercise.
The latest filing, published on 12 May 2017, reports an open-market sale of €14k in Merrimack Pharmaceuticals Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daryl C. Drummond
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,097 shares@ US$3.7258.0% of flowCommon StockSEC:0001209191-17-032046:1
- 4,097 shares@ US$2.6942.0% of flowCommon StockSEC:0001209191-17-032046:0
2 of 2 declarations
